查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1809946

精準診斷和精準醫療市場（按產品、技術、應用和最終用戶分類）—全球預測，2025-2030 年

Precision Diagnostics & Medicine Market by Product, Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

精準診斷與精準醫療市場規模預計在2024年達到1405.7億美元，2025年成長至1551.4億美元，複合年成長率為11.00%，2030年達到2629.6億美元。

主要市場統計數據
基準年2024年 1405.7億美元
預計2025年 1551.4億美元
預測年份 2030 2629.6億美元
複合年成長率（%） 11.00%

探索精準診斷和精準醫療的不斷發展，將數據主導的洞察力與治療創新相結合，以獲得策略優勢

在基因組學、分子生物學和數位健康分析領域的突破下，精準診斷和精準醫療領域正在經歷顯著變革。隨著定序技術日益普及，運算能力不斷提升，醫療保健相關人員正在利用數據主導的洞察，提供標靶治療，改善患者預後。本介紹將幫助您理解這些融合趨勢如何重新定義診斷，實現更早的疾病檢測，並促進個人化治療途徑。

透過人工智慧突破、監管變革和以患者為中心的治療創新，確定再形成精準診斷和精準醫療的關鍵轉型轉變

近年來，一系列變革性變化重塑了精準診斷和精準醫療生態系統。人工智慧和機器學習已成為關鍵推動因素，它們釋放更深層的分子數據，為預測模型提供訊息，並加速生物標記的發現。同時，次世代定序平台的成熟顯著縮短了周轉時間，使臨床決策更加及時，並支持快速識別可操作的基因變異。

評估2025年實施的美國關稅對精準診斷和精準醫療供應鏈、定價和全球夥伴關係的累積影響

2025年美國關稅的實施，為精準診斷和精準醫療領域的相關人員帶來了新的考量。關鍵試劑、定序設備和實驗室耗材的進口關稅導致學術和商業實驗室的採購成本上升。這種關稅環境促使企業重新評估其全球供應鏈，並尋求近岸外包策略，以降低貿易中斷風險，同時確保關鍵材料的可靠供應。

全面的市場理解，包括按產品、技術、應用和最終用戶分類的關鍵細分洞察

深入了解市場區隔對於確定成長路徑和最佳化資源配置至關重要。在產品領域，抗病毒藥物在對抗感染疾病繼續發揮關鍵作用，而細胞和基因療法則推動了個人化介入的前沿發展。抑制劑針對關鍵的分子通路，單株抗體則提供高度特異性的治療方法，每個細分市場都展現出獨特的發展路徑和商業化動態。

來自美洲、歐洲、中東和非洲以及亞太地區的關鍵見解，揭示戰略機會、挑戰和成長催化劑

區域因素在精準診斷和精準醫療的採用和可近性方面發揮關鍵作用。在美洲，強大的研究基礎設施和積極的醫療政策促進了基因組定序和基於價值的醫療模式的早期應用。學術中心和商業公司之間的合作正在加速將研究成果轉化為臨床實踐，監管機構也強調加快審查程序以支持患者獲取相關服務。

透過策略夥伴關係、產品線創新和市場領導策略塑造精準診斷和精準醫療生態系統的知名公司簡介

精準診斷和精準醫療領域的競爭態勢正受到成熟生命科學集團與新興技術創新者融合的影響。領先的開發商正在利用策略夥伴關係關係，整合各自在檢測方法開發、生物標記發現和臨床檢驗方面的優勢，共同開發一體化的診斷和治療解決方案。這些聯盟通常會發展成為共同商業化協議，從而加快市場滲透速度並共用管理風險。

為行業領導者提供可行的建議，以應對不斷變化的市場動態、最佳化創新並加強其在精準醫療領域的競爭地位

為了因應瞬息萬變的精準診斷和精準醫療格局，產業領導者應優先整合人工智慧工具，以增強數據解讀能力、加速生物標記發現並最佳化臨床試驗設計。同時，透過建立區域製造中心來實現供應鏈網路多元化，可以減輕關稅的影響，並提高對貿易政策變化的抵禦能力。採用基於價值的醫療框架並展示臨床效用的真實證據，對於確保報銷和推動醫生採用至關重要。

概述所採用的綜合調查方法，包括主要和次要資料收集、分析框架和檢驗通訊協定，以確保報告的完整性

本報告採用嚴謹的調查方法，整合一手資料和二手資料，確保分析的深度與準確性。一手資料研究包括對高階主管、臨床研究人員和監管專家的深入訪談，以深入觀點創新趨勢、應用障礙和策略重點。同時進行的二手資料研究則利用同行評審文獻、公司出版物和政府政策文件，為研究結果提供背景資訊並檢驗市場發展。

對精準診斷和精準醫療趨勢的結論性見解和策略意義，為相關人員的決策提供資訊並增強市場準備

技術進步、監管動力和病患主導需求的融合，凸顯了精準診斷和精準醫療的變革時期。透過分析，我們揭示了關鍵的主題要務，包括面對不斷變化的貿易政策，需要建立敏捷的供應鏈，細分重點的策略協調，以及區域方法的必要事項。總而言之，這些見解為組織提供了一條利用創新、管理風險和產生臨床影響的前進之路。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 整合人工智慧驅動的多組體學分析，實現個人化癌症治療選擇
  • 擴展液態生物檢體平台以實現早期疾病檢測和監測
  • 採用基於 CRISPR 的診斷技術進行快速即時基因檢測
  • 開發數位雙胞胎模型以最佳化個人化藥物管理策略
  • 奈米孔定序在即時感染疾病監測的應用日益廣泛
  • 引入遠端醫療支援的居家生物標記檢測，用於慢性病管理
  • 放射基因組學中新興的人工智慧演算法可預測腫瘤行為和治療反應
  • 自體自體免疫疾病綜合生物標記組合的多重免疫檢測進展
  • 監管協調加速標靶治療伴隨診斷的全球核准
  • 製藥和科技公司合作開發穿戴式生物感測器，用於持續健康監測

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章精準診斷和精準醫療市場（按產品）

  • 抗病毒藥物
  • 細胞治療和基因治療
  • 抑制劑
  • 單株抗體

第9章 精準診斷與精準醫療市場（按技術）

  • 基因組學
  • 分子診斷
    • 次世代定序
    • PCR
  • 蛋白質體學

第 10 章精準診斷與精準醫療市場（按應用）

  • 疾病診斷
    • 慢性病
    • 遺傳性疾病
  • 精準治療
    • 個人化醫療
    • 標靶治療
  • 研究與開發

第11章精準診斷與精準醫療市場（依最終用戶）

  • 臨床實驗室
    • 診斷實驗室
    • 研究實驗室
  • 醫院

第 12 章：美洲精準診斷與精準醫療市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：歐洲、中東和非洲的精準診斷與精準醫療市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14. 亞太地區精準診斷與精準醫療市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • AstraZeneca PLC
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare Technologies, Inc.
    • Illumina, Inc.
    • International Business Machines Corp.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • Lantheus Medical Imaging, Inc.
    • Medtronic PLC
    • Myriad Genetics Inc.
    • Novartis AG
    • OneOme, LLC
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Sanofi SA
    • Siemens Healthineers
    • Swiss Precision Diagnostics GmbH
    • Thermo Fisher Scientific Inc.

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-50750BF5CD44

The Precision Diagnostics & Medicine Market was valued at USD 140.57 billion in 2024 and is projected to grow to USD 155.14 billion in 2025, with a CAGR of 11.00%, reaching USD 262.96 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 140.57 billion
Estimated Year [2025] USD 155.14 billion
Forecast Year [2030] USD 262.96 billion
CAGR (%) 11.00%

Exploring the evolving landscape of precision diagnostics and medicine where data-driven insights converge with therapeutic innovation for strategic advantage

The landscape of precision diagnostics and medicine has undergone a remarkable evolution, propelled by breakthroughs in genomics, molecular biology, and digital health analytics. As sequencing technologies become more accessible and computational power continues to grow, stakeholders across the healthcare spectrum are harnessing data-driven insights to deliver targeted therapies and improve patient outcomes. This introduction sets the stage for understanding how converging trends are redefining diagnostics, enabling early disease detection, and facilitating personalized treatment pathways.

Moreover, regulatory bodies have increasingly embraced adaptive approval pathways and novel reimbursement models to support innovation in this sector. Public-private partnerships are fostering collaborative ecosystems that expedite clinical validation and streamline commercialization. Concurrently, heightened patient awareness and advocacy are driving demand for tailored diagnostic solutions, compelling industry participants to refine precision medicine strategies. Against this dynamic backdrop, an integrated perspective on emerging technological, regulatory, and patient-centric forces is essential for charting a strategic course in precision diagnostics and medicine.

Identifying pivotal transformative shifts reshaping precision diagnostics and medicine driven by AI breakthroughs, evolving regulations, and patient-centric care innovations

In recent years, a series of transformative shifts have reshaped the precision diagnostics and medicine ecosystem. Artificial intelligence and machine learning have emerged as critical enablers, unlocking deeper layers of molecular data to inform predictive models and accelerate biomarker discovery. At the same time, the maturation of next-generation sequencing platforms has significantly reduced turnaround times, enabling more timely clinical decision-making and supporting the rapid identification of actionable genetic variants.

In parallel, regulatory agencies have introduced more flexible frameworks to manage breakthrough designations and real-world evidence generation. This regulatory realignment has encouraged cross-sector collaborations, uniting biopharmaceutical companies, diagnostic innovators, and healthcare providers in co-development initiatives. Patients are now at the center of care models, exerting influence through direct-to-consumer testing and personalized health tracking. Consequently, industry participants must navigate an environment where technological prowess, regulatory agility, and patient engagement converge to define competitive success.

Evaluating the cumulative impact of the United States tariffs introduced in 2025 on the precision diagnostics and medicine supply chain, pricing, and global collaborations

The implementation of the United States tariffs in 2025 has introduced new considerations for stakeholders in precision diagnostics and medicine. Import duties on key reagents, sequencing instruments, and laboratory consumables have contributed to elevated procurement costs for academic and commercial laboratories alike. This tariff environment has prompted companies to reevaluate global supply chains, exploring nearshoring strategies to mitigate exposure to trade disruptions while ensuring reliable access to critical materials.

In addition, the elevated cost base has spurred increased collaboration with domestic manufacturers and accelerated investments in localized production facilities. As a result, suppliers are adapting their pricing models and exploring alternative sourcing partnerships to maintain competitive margins. Furthermore, the tariffs have underscored the importance of diversified supplier networks and the strategic integration of tariff impact assessments into long-term planning. Organizations that proactively incorporate these elements into their operational frameworks are better positioned to sustain innovation momentum and preserve market access amid shifting trade policies.

Deriving key segmentation insights across product categories, technology platforms, application domains, and end-user environments for comprehensive market understanding

A nuanced understanding of market segmentation is essential for identifying growth corridors and optimizing resource allocation. Within the realm of product offerings, antiviral drugs continue to play a vital role in combating infectious diseases, while cell and gene therapies are advancing the frontier of personalized interventions. Inhibitor drugs target critical molecular pathways, and monoclonal antibodies offer highly specific therapeutic modalities, each segment presenting unique development pathways and commercialization dynamics.

Technology platforms further refine strategic focus, with genomics driving the discovery of genetic variants, molecular diagnostics-spanning next-generation sequencing and polymerase chain reaction-delivering precise molecular profiles, and proteomics elucidating protein interactions and post-translational modifications. Application domains range from disease diagnosis, covering chronic conditions and genetic disorders, to precision therapeutics encompassing personalized medicine and targeted therapies, as well as research and development activities that fuel ongoing innovation. Finally, end-user dynamics influence adoption patterns, as clinical laboratories-both diagnostic and research-and hospitals integrate these solutions into care pathways. By dissecting these layers, organizations can tailor their strategies to align with segment-specific drivers and customer needs.

Interpreting key regional insights across Americas, Europe Middle East Africa, and Asia Pacific highlighting strategic opportunities, challenges, and growth catalysts

Regional considerations play a pivotal role in shaping the adoption and accessibility of precision diagnostics and medicine. In the Americas, robust research infrastructure and proactive health policies have facilitated early uptake of genomic sequencing and value-based care models. Collaboration between academic centers and commercial entities has accelerated the translation of discoveries into clinical practice, while regulatory bodies emphasize expedited review pathways to support patient access.

Across Europe, the Middle East, and Africa, evolving regulatory harmonization efforts are streamlining cross-border clinical trials and encouraging harmonized standards for diagnostics. Public health initiatives in emerging markets are investing in capacity building for molecular testing to address population health challenges. Meanwhile, achieving equitable access remains a priority, driving collaborations between governments, non-profit organizations, and industry partners.

In the Asia-Pacific region, significant investments in biotechnology infrastructure and life sciences research are fueling rapid expansion. Governments are implementing favorable reimbursement schemes to support precision therapeutics, and a growing network of diagnostic laboratories is enhancing capacity for high-throughput sequencing. As a result, industry participants must tailor regional entry strategies to accommodate diverse regulatory landscapes, reimbursement frameworks, and local innovation ecosystems.

Profiling prominent companies shaping the precision diagnostics and medicine ecosystem through strategic partnerships, pipeline innovation, and market leadership strategies

Competitive dynamics in precision diagnostics and medicine are shaped by a blend of established life sciences conglomerates and emerging technology innovators. Leading organizations are leveraging strategic partnerships to co-develop integrated diagnostic-therapeutic solutions, combining strengths in assay development, biomarker discovery, and clinical validation. These alliances often extend into co-marketing agreements, enabling faster market penetration and shared risk management.

Investment in research and development remains a cornerstone of differentiation, with companies channeling resources into proprietary platforms, novel biomarker pipelines, and advanced analytical tools. Mergers and acquisitions have also intensified as global players seek to consolidate capabilities in genomics, proteomics, and companion diagnostics. In parallel, smaller specialist firms are capitalizing on niche expertise by offering modular, cloud-enabled solutions that streamline laboratory workflows and enhance data interpretation.

Intellectual property strategies continue to influence competitive positioning, with patent portfolios securing market exclusivity for breakthrough innovations. As a result, organizations that successfully integrate cross-disciplinary assets and sustain a balanced pipeline of near-term and long-term projects are best positioned to drive leadership in the rapidly evolving precision medicine ecosystem.

Articulating actionable recommendations for industry leaders to navigate evolving market dynamics, optimize innovations, and strengthen competitive positioning in precision medicine

To navigate the dynamic precision diagnostics and medicine landscape, industry leaders should prioritize the integration of artificial intelligence tools to enhance data interpretation, accelerate biomarker discovery, and optimize clinical trial design. Simultaneously, diversifying supply chain networks by establishing regional manufacturing hubs will reduce tariff exposure and improve resilience against trade policy shifts. Embracing value-based care frameworks and demonstrating real-world evidence of clinical utility will be critical for securing reimbursement and driving physician adoption.

Moreover, organizations should foster collaborative ecosystems by engaging with academic institutions, patient advocacy groups, and regulatory authorities to co-create standards for diagnostic validation and personalized therapeutic pathways. Investing in workforce development initiatives will ensure that laboratory personnel and clinicians are equipped to leverage advanced platforms effectively. Finally, cultivating flexible commercialization strategies that adapt to regional regulatory landscapes and healthcare infrastructure variability will enable sustainable growth and global market reach.

Outlining the comprehensive research methodology employed including primary and secondary data collection, analytical frameworks, and validation protocols for report integrity

This report is underpinned by a rigorous research methodology that synthesizes primary and secondary sources to ensure analytical depth and accuracy. Primary research included in-depth interviews with senior executives, clinical researchers, and regulatory experts to capture frontline perspectives on innovation trends, adoption barriers, and strategic priorities. In parallel, secondary research leveraged peer-reviewed literature, company publications, and governmental policy documents to contextualize findings and validate market developments.

Analytical frameworks such as SWOT and PESTEL were employed to systematically evaluate macroeconomic drivers, regulatory shifts, and technological disruptions. Data triangulation techniques were applied to reconcile disparate information sources and enhance confidence in the conclusions drawn. Furthermore, validation protocols involved cross-functional review sessions with industry specialists to refine insights and ensure relevance to diverse stakeholder needs. This comprehensive approach provides a robust foundation for informed decision-making and strategic planning in the precision diagnostics and medicine sector.

Summarizing conclusive insights and strategic implications of precision diagnostics and medicine trends to inform stakeholder decision-making and boost market readiness

The convergence of technological advancements, regulatory momentum, and patient-driven demand underscores a transformative era for precision diagnostics and medicine. Throughout this analysis, key thematic imperatives have emerged: the necessity of agile supply chains in the face of trade policy shifts, the strategic alignment of segmentation priorities, and the tailored adaptation of regional approaches. Collectively, these insights illuminate pathways for organizations to harness innovation, manage risk, and deliver clinical impact.

As industry participants continue to refine their strategies, maintaining a holistic perspective on technological ecosystems, stakeholder collaborations, and emerging policy landscapes will be paramount. By integrating the actionable recommendations and segmentation insights presented herein, decision-makers can confidently navigate complexity, catalyze growth, and ultimately improve patient outcomes. This conclusive synthesis serves as a strategic compass for stakeholders seeking to lead in the dynamic realm of precision diagnostics and medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI-driven multi-omics profiling for personalized cancer therapy selection
  • 5.2. Expansion of liquid biopsy platforms enabling early disease detection and monitoring
  • 5.3. Adoption of CRISPR-based diagnostics for rapid point-of-care genetic testing
  • 5.4. Development of digital twin models to optimize individualized drug dosing strategies
  • 5.5. Growth of nanopore sequencing applications in real-time infectious disease surveillance
  • 5.6. Implementation of telehealth-enabled at-home biomarker testing for chronic disease management
  • 5.7. Emergence of AI algorithms in radiogenomics to predict tumor behavior and therapy response
  • 5.8. Advancement of multiplexed immunoassays for comprehensive biomarker panels in autoimmune disorders
  • 5.9. Regulatory harmonization accelerating global approval of companion diagnostics for targeted therapies
  • 5.10. Collaboration between pharma and tech companies on wearable biosensors for continuous health monitoring

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Precision Diagnostics & Medicine Market, by Product

  • 8.1. Introduction
  • 8.2. Antiviral Drugs
  • 8.3. Cell & Gene Therapies
  • 8.4. Inhibitor Drugs
  • 8.5. Monoclonal Antibodies

9. Precision Diagnostics & Medicine Market, by Technology

  • 9.1. Introduction
  • 9.2. Genomics
  • 9.3. Molecular Diagnostics
    • 9.3.1. Next-Generation Sequencing
    • 9.3.2. Polymerase Chain Reaction
  • 9.4. Proteomics

10. Precision Diagnostics & Medicine Market, by Application

  • 10.1. Introduction
  • 10.2. Disease Diagnosis
    • 10.2.1. Chronic Diseases
    • 10.2.2. Genetic Disorders
  • 10.3. Precision Therapeutics
    • 10.3.1. Personalized Medicine
    • 10.3.2. Targeted Therapies
  • 10.4. Research & Development

11. Precision Diagnostics & Medicine Market, by End User

  • 11.1. Introduction
  • 11.2. Clinical Laboratories
    • 11.2.1. Diagnostic Laboratories
    • 11.2.2. Research Laboratories
  • 11.3. Hospitals

12. Americas Precision Diagnostics & Medicine Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Precision Diagnostics & Medicine Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Precision Diagnostics & Medicine Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. AstraZeneca PLC
    • 15.3.3. Baxter International Inc.
    • 15.3.4. Becton, Dickinson and Company
    • 15.3.5. Biogen Inc.
    • 15.3.6. Bristol-Myers Squibb Company
    • 15.3.7. Danaher Corporation
    • 15.3.8. F. Hoffmann-La Roche Ltd
    • 15.3.9. GE Healthcare Technologies, Inc.
    • 15.3.10. Illumina, Inc.
    • 15.3.11. International Business Machines Corp.
    • 15.3.12. Johnson & Johnson Services, Inc.
    • 15.3.13. Koninklijke Philips N.V.
    • 15.3.14. Lantheus Medical Imaging, Inc.
    • 15.3.15. Medtronic PLC
    • 15.3.16. Myriad Genetics Inc.
    • 15.3.17. Novartis AG
    • 15.3.18. OneOme, LLC
    • 15.3.19. Pfizer Inc.
    • 15.3.20. Qiagen NV
    • 15.3.21. Quest Diagnostics Incorporated
    • 15.3.22. Sanofi S.A.
    • 15.3.23. Siemens Healthineers
    • 15.3.24. Swiss Precision Diagnostics GmbH
    • 15.3.25. Thermo Fisher Scientific Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. PRECISION DIAGNOSTICS & MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. PRECISION DIAGNOSTICS & MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHAI
  • FIGURE 24. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHSTATISTICS
  • FIGURE 25. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHCONTACTS
  • FIGURE 26. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INHIBITOR DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INHIBITOR DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 91. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 92. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 93. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 94. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 103. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 104. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 105. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 106. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 107. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 109. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 110. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 111. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 112. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 113. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 115. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 116. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 117. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 118. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 119. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 121. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 122. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 123. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 126. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 127. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 128. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 129. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 131. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 132. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 133. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 134. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 135. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 139. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 142. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 143. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 144. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 145. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 148. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 149. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 150. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 151. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 154. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 155. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 158. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 159. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 160. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 161. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 163. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 164. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 199. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 200. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 201. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 203. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 204. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 205. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 208. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 209. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 210. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 211. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 213. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 215. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 216. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 217. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 225. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 226. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 227. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 229. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 230. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 231. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 233. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 235. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 236. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 237. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 240. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 241. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 242. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 243. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 246. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 247. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 249. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 252. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 253. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 256. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 257. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 258. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 259. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 262. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 263. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 265. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 269. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 272. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 273. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 274. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 275. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 277. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 278. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRAT